Utility of methylene blue in surgery for primary hyperparathyroidism

Utility of methylene blue in surgery for primary hyperparathyroidism - Methylene blue in surgery for hyperparathyroidism

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031174

Enrollment

200

Registered

2018-02-06

Start date

2000-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperparathyroidism

Interventions

methylene blue

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases with hyperparathyroidism who underwent surgery

Exclusion criteria

Exclusion criteria: Patients who do not give their informed consent.

Design outcomes

Primary

Measure	Time frame
Identification rate for hyperparathyroid glands.	—

Secondary

Measure	Time frame
safty, time for surgery, blood loss, hospital stay, complications	—

Countries

Japan

Contacts

Public ContactTakaaki Fujii

Same as above Same as above

ftakaaki@gunma-u.ac.jp027-220-7111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026